In personalized care for patients, psoriasis biomarkers will be highly relevant. At present, various centers have investigated biomarkers and their clinical significance for psoriasis progression. Read commentary from Andrea Chiricozzi, MD, on three recent publications.
Arcutis Biotherapeutics, Inc. shared their finding from the Skin Insights: Uncovering Psoriasis Survey.
Dermavant announced the FDA approval for VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults. This is the first topical novel chemical entity launched for psoriasis in the U.S. in 25 years.
Bristol Myers Squibb (BMS) announced new two-year data that reinforces the durable efficacy and consistent safety profile of Deucravacitinib when used to treat moderate to severe plaque psoriasis.
The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.
IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member!
Three councilors join the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.
The 2022 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 24 – Tuesday, March 29 in Boston, Massachusetts. The program was packed with sessions showcasing the latest innovations in dermatology and venereology. Grace Hile, MD, has written a congress report with summaries of eleven psoriasis-focused presentations. You can download the full report or read on for a brief look at some of the highlights.
IPC Councilor, Carlo Pincelli, MD, shares his expert opinion on innovative research that connects insights into immunopathogenesis with genetics and modes of action of treatments.
Amgen presents new data on the efficacy of apremilast in patients with mild to moderate plaque psoriasis and in patients with palmoplantar pustulosis.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the initiation of VISIBLE. VISIBLE is a first-of-its-kind, large-scale prospective clinical study dedicated to generating key disease insights among Black, Hispanic, Asian, Indigenous, and other people of color.
The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world to present and discuss cutting-edge issues. You can download the full report or read a summary of some of the highlights.
